Organon & Co. (OGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | ||
| Net Income | 3,218,000 | 2,153,000 |
| Depreciation Amortization | 354,000 | 1,673,000 |
| Other Working Capital | -912,000 | -174,000 |
| Other Operating Activity | 107,000 | 35,000 |
| Operating Cash Flow | $2,767,000 | $3,687,000 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -102,000 | -69,000 |
| Investing Cash Flow | $-102,000 | $-69,000 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | -2,621,000 | -4,164,000 |
| Financing Cash Flow | $-2,621,000 | $-4,164,000 |
| Exchange Rate Effect | 31,000 | 19,000 |
| Beginning Cash Position | 244,000 | 771,000 |
| End Cash Position | 319,000 | 244,000 |
| Net Cash Flow | $75,000 | $-527,000 |
| Free Cash Flow | ||
| Operating Cash Flow | 2,767,000 | 3,687,000 |
| Free Cash Flow | 2,767,000 | 3,687,000 |